CDMO Blog

close

Subscribe to Email Updates

Popular Stories

Viral Aggregation in Downstream Processing of Lentiviral Vectors
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
CDMOs: The Good, the Great and the Exceptional (and How to Tell the Difference)
Five Steps to Ensure Your Cell and Gene Therapy Product Is GMP Compliant
5 Considerations for Scaling-Up PSC-Derived Cell Therapies
21 May 2021

Scaling-Up Production of Pluripotent Stem Cells Part 1: Begin with the End in Mind

Many emerging cell and gene therapies are aimed at using cell replacem...

29 Jan 2020

Induced Pluripotent Stem Cells – Understanding Reprogramming

Stemming (pun intended) from the fundamental question in developmental...

Tell us what you thought about this post.